Researchers study how Mycobacterium tuberculosis can develop resistance to anti-TB drugs - News-Medical.net

-

In July last year, South Africa became the first country to roll out a new anti-tuberculosis drug in its national programme.

This new drug, called bedaquiline, is the first new anti-tuberculosis drug to be developed in four decades. It improves the survival of patients with multidrug resistant TB, potentially offering a shorter treatment time with fewer side effects.

Scientists from Stellenbosch University (SU), in collaboration with a multidisciplinary team of researchers and clinicians, are now trying to conserve this life-saving treatment by studying how Mycobacterium tuberculosis, the bacterium that causes TB, can develop resistance to this drug. Their findings will be used to inform tuberculosis treatment guidelines to ensure that the right combination of anti-tuberculosis drugs are used along with bedaquiline in order to optimize patient treatment outcomes, while minimizing the risk of developing resistance to the drug.

"We need to protect bedaquiline from the development of resistance and therefore it is crucial to understand how quickly and through which mechanisms bedaquiline resistance develops," says Dr Margaretha de Vos, one of the lead authors of a scientific commentary article recently published in the New England Journal of Medicine. The article is based on research by De Vos and colleagues at the Division of Molecular Biology and Human Genetics at SU's Faculty of Medicine and Health Sciences (FMHS).

SU researchers studied the development of bedaquiline resistance in TB bacteria in a 65-year-old patient from Cape Town using a combination of novel techniques. These included (1) whole-genome sequencing of the bacteria in patient samples taken throughout various stages of the disease, (2) targeted deep sequencing of Rv0678, a gene of the bacteria that is associated with bedaquiline resistance, and (3) culture-based drug susceptibility testing.

The study showed that resistance to bedaquiline emerged despite the patient adhering to the standard treatment regimen, which requires bedaquiline to be taken along with at least five antibiotic drugs which the bacterium does not resist.

These results show that it is crucial to increase our efforts to monitor patients receiving bedaquiline and to develop new diagnostic tools to rapidly identify bedaquiline resistance. By rapidly identifying bedaquiline resistance, we will be able change treatment and thereby prevent spread."

Rob Warren, Distinguished Professor in Microbiology and Co-Author of the Article

Related Stories

Helen Cox, one of the senior co-authors of the study, suggests that "while it is important to monitor the emergence of resistance to new drugs such as bedaquiline, these data should not suggest that we restrict access to bedaquiline for the thousands of patients in South Africa who are in dire need of improved treatment for drug-resistant tuberculosis".

Source:

Stellenbosch University

Journal reference:

Vos, M.D. et al. (2019) Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment. New England Journal of Medicine. doi.org/10.1056/NEJMc1815121.



http://bit.ly/2W6uCkF

Comments

Post a Comment

Popular posts from this blog

Manual on meat inspection for developing countries

-
Image
sinusitis treatment :: Article Creator My 'sinus Infection' Turned Out To Be A One In A Million Nasal Cancer At Just 28 - And Doctors Had To Cut My Eye Out To Save Me By Emily Joshu Health Reporter For Dailymail.Com Published: 06:33 EDT, 20 April 2024Updated: 06:35 EDT, 20 April 2024 A 28 year-old California woman has described the shock of being diagnosed with a deadly sinus cancer that affects fewer than one in a million people - and led to the removal of her right eye. The 'golf ball-sized tumor', which had spread throughout her face, was first mistaken for a sinus infection by the woman's doctors.  Annika, who posts about her condition on TikTok, woke up one morning in 2023 and noticed that the inner corner of her right eye was sore.  While she at first thought nothing of it, by the time the evening rolled around, 'my face started to really, really hurt on the right side,' she said in a video.  The next day, her
Read more

Rash behind ear: Causes, other symptoms, and treatment - Medical News Today

-
Image
A rash behind the ear may occur due to a variety of different medical conditions. Certain viral infections and autoimmune diseases may cause a rash behind the ear in both children and adults. While some causes, such as contact dermatitis, are not concerning, other causes, including rubella, may be more serious. In this article, we look at some of the causes of a rash behind the ear, as well as the other symptoms that they may produce and how to treat them. Contact dermatitis is an allergic reaction to a particular substance. If an allergy-inducing substance comes into contact with the skin behind the ear, a rash can form. Allergens that may cause contact dermatitis behind the ears include: shampoos soaps other hair care products For example, hair dye products contain an ingredient called paraphenylenediamine (PPD), which is a common contact allergen. Symptoms Contact dermatitis causes itchiness, dryness, and flaking of the skin that came into contact with the allergen. Diagnosis A doc
Read more

Having This One Particular Blood Type Can Help Protect You From Severe Malaria - ScienceAlert

-
Image
Nearly  half the world's population is at risk of malaria, one of the most deadly diseases known to humankind. Each year it claims  over 400,000 lives, most of whom are children younger than age five. While it's possible to vaccinate against malaria, virtually all of these cases are in the African region, where protection is often nothing more than a roll of the dice. Now, a recent  analysis  of 23 papers suggests those with blood type O have the genetic odds stacked in their favour. In sub-Saharan Africa, where severe malaria - caused by the  Plasmodium falciparum  parasite  - is endemic, there are far more individuals with blood type O than anywhere in Europe or the US. In Nigeria alone, where 97 percent of the country is at risk of malaria, more than half the population belongs to this blood group. In Ethiopia and many others, the numbers are similar. Rather than a coincidence, co-author and epidemiologist Abraham Degarege Mengist from Robert Stempel College of Publi
Read more